PARTNERS

Bidibots proudly supports the Emerikus Land Foundation

Emerikus Land Foundation is a non for profit organisation dedicated to supporting bereaved parents through the loss of their baby/s, Started in 2013 after Ben & Sherri-Leigh Land lost their daughter Emerikus due to a placental abruption at almost full term!

Ben & Sherri-Leigh founded Emerikus Land Foundation in August 2013 to donate cuddle cots to maternity hospitals through out Australia while also having donated to hospitals in New Zealand, Cuddle Cots allow parents 5-7 days with their baby in the comfort of their own room to say their final goodbyes but more importantly to say Hello.

Without a cuddle cot parents have no other option but to allow their baby/s be taken to the morgue to be cool to slow deteriorating.

Emerikus Land Foundation also donates Memory Boxes to hospitals for parents to create positive memories of their baby/s.

Giving parents the “Gift Of Time”

The Bidibots company has made considerable progress in its commercialization of Neonatal products, activities in leading respiratory products and other neonatal developments in Australia.

As part of our growth strategy, Bidibots has appointed, highly qualified healthcare distributors Parker Healthcare, they will be our key distributors for the Australia, New Zealand and Asian markets.

Parker Healthcare specializes in the distribution of Anesthetic and Neonatal products, and is a leader in the service and development of devices for the acute and neonatal critical care markets.

The Bidibots company has made considerable progress in its commercialization of Neonatal products, activities in leading respiratory products and other neonatal developments in Australia.

As part of our growth strategy, Bidibots has appointed, highly qualified healthcare distributors Parker Healthcare, they will be our key distributors for the Australia, New Zealand and Asian markets.

Parker Healthcare specializes in the distribution of Anesthetic and Neonatal products, and is a leader in the service and development of devices for the acute and neonatal critical care markets.